HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pharmacokinetics of double-dose raltegravir in two patients with HIV infection and tuberculosis.

AuthorsDavid M Burger, Cecile Magis-Escurra, Guido El van den Berk, Luc B S Gelinck
JournalAIDS (London, England) (AIDS) Vol. 24 Issue 2 Pg. 328-30 (Jan 16 2010) ISSN: 1473-5571 [Electronic] England
PMID20029272 (Publication Type: Case Reports, Letter)
Chemical References
  • Anti-HIV Agents
  • Antibiotics, Antitubercular
  • Pyrrolidinones
  • Raltegravir Potassium
  • Rifampin
Topics
  • AIDS-Related Opportunistic Infections (drug therapy, metabolism)
  • Adult
  • Anti-HIV Agents (administration & dosage, pharmacokinetics)
  • Antibiotics, Antitubercular (administration & dosage)
  • HIV-2 (drug effects)
  • Humans
  • Male
  • Middle Aged
  • Pyrrolidinones (administration & dosage, pharmacokinetics)
  • Raltegravir Potassium
  • Rifampin (administration & dosage)
  • Tuberculosis (drug therapy, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: